Total Payments
$5,854
2024 Payments
$909.50
Companies
14
Transactions
111
Medicare Patients
1,505
Medicare Billing
$265,136
Payment Breakdown by Category
Food & Beverage$4,654 (79.5%)
Other$1,200 (20.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,654 | 110 | 79.5% |
| Honoraria | $1,200 | 1 | 20.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alimera Sciences, Inc. | $2,174 | 26 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $928.45 | 25 | $0 (2024) |
| Genentech USA, Inc. | $533.64 | 9 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $494.68 | 4 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $340.30 | 6 | $0 (2024) |
| Coherus Biosciences Inc. | $277.25 | 10 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $234.26 | 6 | $0 (2024) |
| EyePoint Pharmaceuticals US, Inc. | $196.55 | 5 | $0 (2023) |
| Biogen, Inc. | $145.25 | 6 | $0 (2024) |
| Astellas Pharma US Inc | $132.78 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $909.50 | 29 | Mallinckrodt Hospital Products Inc. ($161.90) |
| 2023 | $1,517 | 40 | Regeneron Healthcare Solutions, Inc. ($327.24) |
| 2022 | $1,338 | 26 | Regeneron Healthcare Solutions, Inc. ($386.35) |
| 2021 | $1,786 | 12 | Alimera Sciences, Inc. ($1,511) |
| 2020 | $163.62 | 3 | Regeneron Pharmaceuticals, Inc. ($103.87) |
| 2019 | $139.88 | 1 | Genentech USA, Inc. ($139.88) |
All Payment Transactions
111 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $32.19 | General |
| Category: Ophthalmology | ||||||
| 12/18/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Ophthalmology | ||||||
| 12/05/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 11/21/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $30.61 | General |
| Category: Ophthalmology | ||||||
| 11/12/2024 | Genentech, Inc. | Susvimo (Drug), Vabysmo | Food and Beverage | In-kind items and services | $94.85 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/07/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $32.39 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/17/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $31.75 | General |
| Category: Ophthalmology | ||||||
| 10/11/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 10/10/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $116.96 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: IMMUNOLOGY | ||||||
| 09/05/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $32.27 | General |
| Category: Ophthalmology | ||||||
| 08/29/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/22/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $29.42 | General |
| Category: Ophthalmology | ||||||
| 08/15/2024 | Biogen, Inc. | BYOOVIZ (Biological) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: Ophthalmology | ||||||
| 06/14/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Ophthalmology | ||||||
| 06/07/2024 | Biogen, Inc. | BYOOVIZ (Biological) | Food and Beverage | In-kind items and services | $28.64 | General |
| Category: Ophthalmology | ||||||
| 05/10/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $31.00 | General |
| Category: Ophthalmology | ||||||
| 04/18/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/11/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $32.12 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/11/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: Ophthalmology | ||||||
| 03/21/2024 | Biogen, Inc. | BYOOVIZ (Biological) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Ophthalmology | ||||||
| 03/19/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 03/13/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Ophthalmology | ||||||
| 02/22/2024 | Coherus Biosciences Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 790 | 1,631 | $393,670 | $141,135 |
| 2022 | 10 | 483 | 911 | $264,940 | $98,222 |
| 2021 | 7 | 140 | 175 | $42,135 | $13,623 |
| 2020 | 5 | 92 | 95 | $48,619 | $12,157 |
Total Patients
1,505
Total Services
2,812
Medicare Billing
$265,136
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 16 | 94 | $140,000 | $61,190 | 43.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 187 | 412 | $75,640 | $36,149 | 47.8% |
| 92134 | Imaging of retina | Office | 2023 | 190 | 478 | $62,430 | $13,633 | 21.8% |
| 67028 | Injection of drug into eye | Office | 2023 | 45 | 152 | $67,300 | $12,918 | 19.2% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 71 | 71 | $14,200 | $6,332 | 44.6% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 23 | 54 | $6,385 | $3,012 | 47.2% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 27 | 28 | $5,150 | $2,763 | 53.7% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 130 | 230 | $13,580 | $2,628 | 19.4% |
| 92250 | Photography of the retina | Office | 2023 | 79 | 85 | $7,240 | $2,069 | 28.6% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 22 | 27 | $1,745 | $438.33 | 25.1% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 11 | 70 | $105,000 | $50,228 | 47.8% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 81 | 181 | $36,200 | $16,796 | 46.4% |
| 67028 | Injection of drug into eye | Office | 2022 | 24 | 85 | $47,000 | $7,850 | 16.7% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 80 | 80 | $16,000 | $7,763 | 48.5% |
| 92134 | Imaging of retina | Office | 2022 | 90 | 223 | $33,450 | $6,619 | 19.8% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 35 | 35 | $7,000 | $3,171 | 45.3% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 16 | 44 | $5,500 | $2,402 | 43.7% |
| 92250 | Photography of the retina | Office | 2022 | 74 | 75 | $6,375 | $1,858 | 29.1% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2022 | 54 | 87 | $6,090 | $1,028 | 16.9% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2022 | 18 | 31 | $2,325 | $506.18 | 21.8% |
| 67042 | Removal of membrane from the retina, pars plana approach with removal of internal limiting membrane of retina | Facility | 2021 | 20 | 20 | $17,632 | $4,597 | 26.1% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 26 | 26 | $5,970 | $3,011 | 50.4% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 17 | 26 | $5,330 | $2,413 | 45.3% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 29 | 49 | $7,350 | $1,474 | 20.0% |
| 92235 | Imaging of blood vessels in back of eye using fluorescein dye | Office | 2021 | 13 | 13 | $2,600 | $1,098 | 42.2% |
About Dr. Daniel Salisbury, M.D
Dr. Daniel Salisbury, M.D is a Ophthalmology healthcare provider based in Baton Rouge, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/26/2015. The National Provider Identifier (NPI) number assigned to this provider is 1801280995.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Salisbury, M.D has received a total of $5,854 in payments from pharmaceutical and medical device companies, with $909.50 received in 2024. These payments were reported across 111 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($4,654).
As a Medicare-enrolled provider, Salisbury has provided services to 1,505 Medicare beneficiaries, totaling 2,812 services with total Medicare billing of $265,136. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Baton Rouge, LA
- Active Since 03/26/2015
- Last Updated 07/22/2024
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1801280995
Products in Payments
- ILUVIEN (Drug) $2,125
- EYLEA (Biological) $1,010
- EYLEA HD (Biological) $412.98
- Cimerli (Biological) $375.42
- ACTHAR (Biological) $340.30
- VABYSMO (Drug) $262.84
- YUTIQ (Drug) $202.49
- Syfovre (Drug) $151.31
- Lucentis (Biological) $139.88
- Vabysmo (Drug) $130.92
- Izervay (Drug) $118.21
- BYOOVIZ (Biological) $98.33
- Susvimo (Drug) $94.85
- IHEEZO (Drug) $71.34
- Stellaris (Device) $63.15
- XIPERE (Drug) $48.02
- DEXYCU (Drug) $42.71
- XIIDRA (Drug) $21.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Baton Rouge
Dr. Blake Williamson, M.d., M.p.h., M.s, M.D., M.P.H., M.S
Ophthalmology — Payments: $505,594
Ophthalmology $505,594
Dr. Charles Williamson, Md, MD
Ophthalmology — Payments: $20,429
Ophthalmology $20,429
Dr. Michael Morgan, M.d, M.D
Ophthalmology — Payments: $8,833
Ophthalmology $8,833
Dr. David Fargason, Md, MD
Ophthalmology — Payments: $6,963
Ophthalmology $6,963
Mr. George Fivgas, Md, MD
Ophthalmology — Payments: $6,495
Ophthalmology $6,495
Dr. Fay Woo, Md, MD
Ophthalmology — Payments: $5,830
Ophthalmology $5,830